2021 Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum – A CME Teaching Activity
Release Date
02/15/21
AMA PRA Category 1 Credit(s)™:
10.25
Category A CE Credits:
About This CME Teaching Activity
This continuing education activity reviews best practices in the growing field of radiotheragnostics (aka theranostics or theragnostics) for benign and malignant diseases, beginning with the fundamentals and extending to include advanced clinical applications. A review of historically established therapies that have been optimally modernized as well as the recently introduced state-of-the-art modalities are included. The expert faculty discuss the optimization of the radiotheragnostic practices for best utilization of various radiopharmaceuticals in contemporary health care delivery systems, both academic and private practice settings.